Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003308 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
A Phase 2 study of Ovarian Cancer and Sarcoma, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Study locations
NCT00003308 is a Phase 2 study of Ovarian Cancer and Sarcoma that has completed, run by Eastern Cooperative Oncology Group. The trial reports 14 study locations across 9 states.
The verdict
NCT00003308, a Phase 2 study of Ovarian Cancer and Sarcoma, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14
- Study locations
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients with newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.
Conditions Studied
Interventions
- RADIATION stereotactic radiosurgery
Study Locations (14)
Iowa
- Iowa Methodist Medical Center - Des Moines
- Mercy Medical Center - Des Moines
- Iowa Lutheran Hospital - Des Moines
Wisconsin
- CCOP - St. Vincent Hospital Cancer Center, Green Bay - Green Bay
- Veterans Affairs Medical Center - Madison - Madison
- University of Wisconsin Comprehensive Cancer Center - Madison
Other
- Instituto de Enfermedades Neoplasicas - Lima
- San Juan City Hospital - San Juan
Michigan
- CCOP - Kalamazoo - Kalamazoo
Nebraska
- Alegent Health-Midlands Community Hospital - Papillion
New Mexico
- MBCCOP - University of New Mexico HSC - Albuquerque
Ohio
- Ireland Cancer Center - Cleveland
Pennsylvania
- Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-02-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003308
The ClinicalTrials.gov registry entry for NCT00003308 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which stereotactic radiosurgery is the first listed.
NCT00003308 reports 14 study locations spanning 9 distinct geographic areas - top geographies include Iowa, Wisconsin, Other.
Frequently Asked Questions
What is clinical trial NCT00003308 about?
NCT00003308 is a clinical study titled "Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients with newly diagnosed brain metastases from kidney cancer, melanoma, or sarcoma.
What is the current status of trial NCT00003308?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-02-02.
What conditions does trial NCT00003308 study?
This clinical trial studies the following conditions: Ovarian Cancer, Sarcoma, Metastatic Cancer, Kidney Cancer, Melanoma (Skin).
What interventions are being tested in trial NCT00003308?
The interventions under investigation include: stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00003308?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00003308 being conducted?
This trial has 14 study locations across Iowa, Michigan, Nebraska, New Mexico, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
RECRUITING · Phase 2
-
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
RECRUITING · Phase 2
-
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
RECRUITING · Phase 2
-
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RECRUITING · Phase 2
-
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RECRUITING · Phase 2
-
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.